Calling Giants: A Perpetual Berkshire-Grade Strategy for Regen

We work in a thin market. If you run a large book or a long-view treasury, one ask: take a steady position in $REGEN and buy verified ecocredits on a schedule. Not a splash. A policy. Slow, public, boring enough to trust.

Why this matters: stable depth and dependable offtake pay real people for real work on land. Without that, the rest is noise.

If you’re a major allocator (insurance, utility, family office, foundation, corporate treasury), reply here to request the one-pager. It covers what to buy, where to buy, basic guardrails, and how we’ll report. No heroics—just a standing bid and monthly credit purchases with a small retire-on-purchase.

We’ll coordinate drafting via DaoDAO so edits and decisions are public.

Everyone else: keep us honest. Push on venues, methodologies, custody, language. If something feels squishy, say it. We’ll fix it in the open.

If this reads as “possible,” reply in-thread. If not, drop the blocker in one sentence—we’ll address that first.

1 Like

I like the thrust here.

I also notice by the wording / phraseology it seems to have been written by gpt.

1 Like

Why a patient allocator enters now (upside in plain terms):

  • Insurance: early data for underwriting; low-drama exposure to nature-linked assets; reputational lift with audited retirements.
  • Utilities: hedge regulatory/climate risk; align procurement with decarbonization mandates; public, rules-based reporting.
  • Family offices: non-correlated sleeve with visible impact; first-mover access and policy influence without headline risk.
  • Foundations/endowments: program-related spend that compounds; clean audit trail; board-level proof of real outcomes.
  • Corporate treasuries: predictable offtake toward targets; supplier/brand resilience; simple, repeatable policy.

Common to all: small, steady, auditable. Option value if this market scales; limited downside if it doesn’t.

Guardrails we offer: venue + methodology whitelist, retire-on-purchase, slippage/depth targets, plain monthly reports.

Appreciate the read, Gregory. I tightened the top post to one screen and one clear ask, per your note. The brief we share on request is numbers-forward (venues/methods, risk controls, reporting) and avoids buzz. If anything still reads fuzzy, I’m happy to fix it in public.